Wesleyan Assurance Society’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,300
Closed -$27K 104
2024
Q2
$27K Hold
1,300
﹤0.01% 101
2024
Q1
$24K Hold
1,300
﹤0.01% 99
2023
Q4
$19K Hold
1,300
﹤0.01% 101
2023
Q3
$23K Sell
1,300
-5,700
-81% -$119K ﹤0.01% 99
2023
Q2
$146K Hold
7,000
0.02% 99
2023
Q1
$165K Hold
7,000
0.02% 97
2022
Q4
$196K Hold
7,000
0.02% 94
2022
Q3
$164K Hold
7,000
0.03% 94
2022
Q2
$236K Hold
7,000
0.03% 92
2022
Q1
$245K Hold
7,000
0.03% 92
2021
Q4
$213K Sell
7,000
-2,900
-29% -$94.5K 0.03% 91
2021
Q3
$325K Hold
9,900
0.04% 89
2021
Q2
$299K Buy
+9,900
New +$326K 0.04% 87

Other funds holding OGN

Wesleyan Assurance Society's OGN Position: Q3 2024 in Review

Wesleyan Assurance Society sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 1,300 shares — an estimated $27K sold.

Wesleyan Assurance Society first reported a position in OGN in Q2 2021 and held it in 13 quarters. The position peaked at $325K in Q3 2021. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • Wesleyan Assurance Society reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
  • Wesleyan Assurance Society sold 1,300 Organon & Co shares in Q3 2024, an estimated $27K.
  • Wesleyan Assurance Society first reported a position in Organon & Co in Q2 2021 and held it in 13 quarters.
  • Wesleyan Assurance Society's Organon & Co position peaked at $325K in Q3 2021.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Wesleyan Assurance Society's 13F filing for Q3 2024, filed 13 Nov 2024.